Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/05/24 | $16,000,000 | Series A |
Solas Bioventures TVM Capital Life Science | undisclosed |
